Jd Capital Management Has Lifted Its Regeneron Pharmaceuticals (REGN) Position; Shorts at Masco (MAS) Lowered By 25.3%

October 12, 2017 - By Linda Rogers

Masco Corporation (NYSE:MAS) had a decrease of 25.3% in short interest. MAS’s SI was 6.71M shares in October as released by FINRA. Its down 25.3% from 8.98 million shares previously. With 2.20M avg volume, 3 days are for Masco Corporation (NYSE:MAS)’s short sellers to cover MAS’s short positions. About 122,842 shares traded. Masco Corp (NYSE:MAS) has risen 18.02% since October 12, 2016 and is uptrending. It has outperformed by 1.32% the S&P500.

Jd Capital Management Llc increased Regeneron Pharmaceuticals (REGN) stake by 55.8% reported in 2017Q2 SEC filing. Jd Capital Management Llc acquired 8,004 shares as Regeneron Pharmaceuticals (REGN)’s stock rose 21.24%. The Jd Capital Management Llc holds 22,347 shares with $10.98 million value, up from 14,343 last quarter. Regeneron Pharmaceuticals now has $47.95 billion valuation. The stock declined 1.21% or $5.47 reaching $447.5 on the news. About 56,823 shares traded. Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has risen 17.40% since October 12, 2016 and is uptrending. It has outperformed by 0.70% the S&P500.

Since May 12, 2017, it had 1 buy, and 7 insider sales for $42.75 million activity. 9,295 Regeneron Pharmaceuticals Inc (NASDAQ:REGN) shares with value of $4.26 million were sold by VAGELOS P ROY. $1.35 million worth of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) was sold by BROWN MICHAEL S. 136,050 Regeneron Pharmaceuticals Inc (NASDAQ:REGN) shares with value of $65.06 million were bought by Sanofi. $9.90M worth of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) shares were sold by Terifay Robert J. On Thursday, June 1 STAHL NEIL sold $1.35 million worth of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) or 2,812 shares. GOLDSTEIN JOSEPH L also sold $482,550 worth of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) shares.

Investors sentiment increased to 1.38 in Q2 2017. Its up 0.12, from 1.26 in 2017Q1. It is positive, as 42 investors sold REGN shares while 157 reduced holdings. 84 funds opened positions while 190 raised stakes. 71.53 million shares or 1.38% more from 70.55 million shares in 2017Q1 were reported. Warren Averett Asset Mgmt Ltd Liability Com invested in 431 shares or 0.05% of the stock. Moreover, Carroll Financial has 0% invested in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) for 82 shares. Fjarde Ap stated it has 0.18% in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Bancorp Of Montreal Can holds 0.02% or 42,414 shares. Tci Wealth Advisors Incorporated owns 3 shares for 0% of their portfolio. Meiji Yasuda Asset Management accumulated 1,677 shares. Verition Fund Mgmt Limited Liability holds 0.09% or 1,915 shares in its portfolio. Bessemer Grp owns 63 shares or 0% of their US portfolio. Gardner Lewis Asset LP reported 3,335 shares. Vantage Investment Advsrs Lc accumulated 0.02% or 167 shares. 166 were accumulated by Ftb Advsrs. Bennicas Associates holds 0.84% or 1,900 shares in its portfolio. Qcm Cayman reported 595 shares stake. Adirondack Trust Company has 0.04% invested in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) for 100 shares. Girard Ltd reported 543 shares.

Among 28 analysts covering Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), 13 have Buy rating, 1 Sell and 14 Hold. Therefore 46% are positive. Regeneron Pharmaceuticals Inc. had 89 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was upgraded by UBS on Monday, September 7 to “Buy”. The rating was upgraded by Chardan Capital Markets on Monday, December 12 to “Neutral”. Credit Suisse upgraded Regeneron Pharmaceuticals Inc (NASDAQ:REGN) rating on Thursday, August 3. Credit Suisse has “Buy” rating and $48500 target. The stock of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has “Outperform” rating given on Monday, August 3 by Leerink Swann. The firm has “Buy” rating by Leerink Swann given on Monday, June 12. The firm has “Neutral” rating by Credit Suisse given on Wednesday, January 20. As per Monday, August 10, the company rating was maintained by TH Capital. The stock of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has “Hold” rating given on Monday, June 5 by Jefferies. Canaccord Genuity maintained Regeneron Pharmaceuticals Inc (NASDAQ:REGN) rating on Wednesday, August 5. Canaccord Genuity has “Buy” rating and $700 target. The stock of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) earned “Buy” rating by UBS on Friday, August 4.

Among 19 analysts covering Masco (NYSE:MAS), 15 have Buy rating, 0 Sell and 4 Hold. Therefore 79% are positive. Masco had 40 analyst reports since July 28, 2015 according to SRatingsIntel. Jefferies maintained the stock with “Buy” rating in Wednesday, May 31 report. The stock of Masco Corp (NYSE:MAS) has “Outperform” rating given on Wednesday, April 26 by RBC Capital Markets. The stock has “Neutral” rating by M Partners on Tuesday, July 28. Robert W. Baird maintained Masco Corp (NYSE:MAS) on Monday, August 28 with “Buy” rating. The firm has “Overweight” rating by Barclays Capital given on Friday, January 6. The stock has “Buy” rating by RBC Capital Markets on Friday, July 28. The stock of Masco Corp (NYSE:MAS) earned “Buy” rating by Bank of America on Friday, September 23. The company was maintained on Monday, October 9 by RBC Capital Markets. The firm earned “Buy” rating on Friday, September 29 by Robert W. Baird. The stock has “Equal-Weight” rating by Barclays Capital on Tuesday, October 13.

Since May 4, 2017, it had 0 insider purchases, and 5 sales for $5.93 million activity. MANOOGIAN RICHARD A had sold 60,323 shares worth $2.24 million on Monday, May 22. VAN LOKEREN MARY ANN also sold $142,317 worth of Masco Corp (NYSE:MAS) on Thursday, May 4. $171,774 worth of Masco Corp (NYSE:MAS) was sold by Straber Renee on Thursday, June 15.

Investors sentiment increased to 1.06 in Q2 2017. Its up 0.21, from 0.85 in 2017Q1. It increased, as 43 investors sold Masco Corp shares while 185 reduced holdings. 81 funds opened positions while 160 raised stakes. 275.10 million shares or 0.29% more from 274.32 million shares in 2017Q1 were reported. Td Asset Management, Ontario – Canada-based fund reported 737,478 shares. British Columbia Inv Mngmt Corp has 189,017 shares for 0.06% of their portfolio. California State Teachers Retirement Sys holds 0.05% or 598,921 shares in its portfolio. Nbw Limited Liability Corp holds 1.1% in Masco Corp (NYSE:MAS) or 103,886 shares. Ajo Ltd Partnership invested in 3.17M shares. Arrow Corporation accumulated 98,888 shares. Godshalk Welsh Cap Management holds 14,550 shares. State Street Corporation holds 0.05% or 14.92 million shares. Archford Strategies Lc holds 104 shares. Tower Research Cap Limited Liability Company (Trc) owns 257 shares for 0% of their portfolio. Virtus Advisers Incorporated invested 0.21% of its portfolio in Masco Corp (NYSE:MAS). Montag A Associates accumulated 126,601 shares or 0.54% of the stock. Marshwinds Advisory reported 22,100 shares or 0.4% of all its holdings. State Treasurer State Of Michigan accumulated 105,104 shares. Parametric Portfolio Limited Company owns 717,736 shares.

Masco Corporation designs, manufactures, markets and distributes branded home improvement and building products. The company has market cap of $12.46 billion. The Firm operates through four business divisions: Plumbing Products, Decorative Architectural Products, Cabinetry Products, and Windows and Other Specialty Products. It has a 23.99 P/E ratio. The Company’s portfolio of brands includes BEHR paint; DELTA and HANSGROHE faucets, bath and shower fixtures; KRAFTMAID and MERILLAT cabinets; MILGARD windows and doors, and HOT SPRING spas.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>